Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 14, 2004 - Issue 3
Submit an article Journal homepage
46
Views
0
CrossRef citations to date
0
Altmetric
Review

IL-10-related cellular cytokines and their receptors: new targets for inflammation and cancer therapy

Francis J Dumont Merck Research Laboratories, PO Box 2000, Rahway 07065 NJ, USA. [email protected]
Pages 281-299 | Published online: 02 Mar 2005

Bibliography

  • MOORE KW, DE WAAL MALEFYT R, COFFMAN RL, O'GARRA A: Interleukin-10 and the interleukin-10 receptor. Ann. Rev Immunol (2001) 19:683–765.
  • ASADULLAH K, STERRYW, VOLK HD: Interleukin -10 therapy - review of a new approach. Pharmacol Rev. (2003) 55:241–269.
  • REDPATH S, GHAZAL P, GASCOIGNE NR: Hijacking and exploitation of IL-10 by intracellular pathogens. Trends Microbial. (2001) 9:86–92.
  • DUMONT FJ: Therapeutic potential of IL -10 and its viral homologues: an update. Expert Opin. Ther. Patents (2003) 13:1551–1557.
  • •Recent review of the biology and therapeutic potential of IL-10 and its viral homologues.
  • FICKENSCHER H, HORS, KUPERS H et al: The interleukin-10 family of cytokines. Trends Immunol (2002) 23:89–96.
  • •Review of the molecular biology of IL-10-related cytokines and their receptors.
  • KOTENKO SV: The family of IL-10- related cytokines and their receptors: related, but to what extent? Cytokine Growth Factor Rev (2002) 13:223–240.
  • •Review of the molecular biology of IL-10-related cytokines and their receptors.
  • RENAULD JC: Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nat. Rev brimanol. (2003) 3:667–676.
  • SAUANE M, GOPALKRISHNAN RV, SARKAR D et al.: MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine. Cytokine Growth Factor Rev (2003) 14:35–51.
  • •Excellent up-to-date review of IL-24 and its potential for anti-cancer gene therapy.
  • GALLAGHER G, DICKENSHEETS H, ESKDALE J et al.: Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Inman. (2000) 1:442–450.
  • ••Description of IL-19 and its homology toIL–10.
  • LIAO YC, LIANG WG, CHEN FW et aL: IL-19 induces production of IL-6 and TNF-a and results in cell apoptosis through TNF-a. Immunol (2002) 169:4288–4297.
  • ••Shows that IL-19 has irnmunostimulatoryactivity in vitro.
  • CHANG C, MAGRACHEVA E, KOZLOV S et al.: Crystal structure of interleukin-19 defines a new subfamily of helical cytokines.j Biol. Chem. (2003) 278:3308–3313.
  • ••Characterisation of the structure of IL-19.Shows that, unlike IL-10, IL-19 does not form an intercalating dimer but exists as a monomer in solution.
  • WOLK K, KUNZ S, ASADULLAH K, SABAT R: Immune cells as sources and targets of the IL-10 family members? Immunol (2002) 168:5397–5402.
  • ••Shows that IL-10-related cytokines areproduced by immune cells.
  • GHORESCHE K, THOMAS P BREIT S et al.: Interleukin-4 therapy of psoriasis induces TH2 responses and improves human autoimmune disease. Nat. Med. (2003) 9:40–46.
  • ROMER J, HASSELAGER E, NORBY PL et al.: Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine A or calcipotriol. J. Invest. Dermatol (2003) 121:1306–1311.
  • ••Shows that IL-19 and IL-20 are producedby keratinocytes in psoriasis.
  • BLUMBERG H, CONKLIN D, XU WF et al.: Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell (2001) 104:9–19.
  • ••Description of IL-20 and of one of itsfunctional receptors, IL-20R1/1L-20R2. Suggests a role for IL-20 in skin biology and inflammation, including psoriasis.
  • KINGO K, KOKS S, NIKOPENSIUS T, SILM H, VASAR E: Polymorphisms in the interleukin-20 gene: relationships to plaque-type psoriasis. Genes Litman. (2004) [Epub ahead of print].
  • SMEETS TJM, CHANDRASEKHER YA, KRAAN MC, HARINGMAN JJ, TAK PP: Interleukin-20 is expressed in inflamed synovium of patients with psoriatic arthritis and rheumatoid arthritis. ACR Meeting Orlando, USA (2003) Abst 21.
  • XU W, CHANDRASEKHER Y, HAUGEN H et al: IL-20 and IL-22 in psoriasis. Ear. Cytokine Netw. (2003) 14:65.
  • DUMOUTIER L, LOUAHED J, RENAULD JC: Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIE), a novel cytokine structurally related to IL-10 and inducible by IL-9. J. Immunol. (2000) 164:1814–1819.
  • DUMOUTIER L, VAN ROOST E, COLAU D, RENAULD JC: Human interleukin-10-related T-cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc. Nat! Acad. SclUSA (2000) 97:10144–10149.
  • ••Description of human IL-22 andcharacterisation of its role as an inducer of acute-phase proteins.
  • XIE MH, AGGARWAL S, HO WH et al: Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. Biol . Chem. (2000) 275:31335–31339.
  • ••Description of human IL-22 anddemonstration that it signals through the IL -22R1/IL-10R2 receptor complex.
  • DUMOUTIER L, VAN ROOST E, AMEYE G, MICHAUX L, RENAULD JC: IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes. Genes Inainuna (2000) 1:488–494.
  • NAGEM RA, COLAU D, DUMOUTIER L et al.: Crystal structure of recombinant human interleukin-22. Structure (Carob) (2002) 10:1051–1062.
  • ••Structural analysis of IL-22 and evidencethat it exists as a monomer in solution.
  • LOGSDON NJ, JONES BC, JOSEPHSON K, COOK J, WALTER MR: Comparison of interleukin-22 and interleukin-10 soluble receptor complexes. .1. Interferon Cytokine Res. (2002) 22:1099–1112.
  • JIANG H, UN JJ, SU ZZ, GOLDSTEIN NI, FISHER PB: Subtraction hybridization identifies a novel melanoma differentiation-associated gene, inda-7, modulated during human melanoma differentiation, growth and progression. Oncogene (1995) 11:2477–2486.
  • •Discovery of the human IL-24 gene.
  • HUANG EY, MADIREDDI MT, GOPALKRISHNAN RV et al.: Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (inda-4 gene with cancer-specific growth suppressing and apoptosis-inducing properties. Oncogene (2001) 20:7051–7063.
  • CAUDELL EG, MUMM JB, POINDEXTER N et al.: The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24. J. Ioannina (2002) 168:6041–6046.
  • ••Demonstration that IL-24 acts as acytokine with irmrtunostimulatory properties.
  • WANG M, TAN Z, ZHANG R, KOTENKO SV, LIANG P: Interleuldn 24 (MDA-7/M0B-5) signals through two heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2. I Biol. Chem. (2002) 277:7241–7347.
  • ••Demonstration that IL-24 acts as acytokine that signals through two distinct receptors.
  • SCHAEFER G, VENKATARAMAN C, SCHINDLER U: FISP (IL-4-induced secreted protein), a novel cytokine-like molecule secreted by TH2 cells. J. Immuna (2001) 166:5859–5863.
  • SOO C, SHAW WW, FREYMILLER E et al.: Cutaneous rat wounds express c49a, a novel gene with homology to the human melanoma differentiation associated gene, mda-7. Cell. Biochem. (1999) 74:1–10.
  • ZHANG R, TAN Z, LIANG P: Identification of a novel ligand-receptor pair constitutively activated by ras oncogenes. J. Biol. Chem. (2000) 275:24436–24443.
  • JONES BC, LOGSDON NJ, JOSEPHSON K et al.: Crystal structure of human cytomegalovirus IL-10 bound to soluble human IL-10R1. Proc. Nat] Acad. Sci.USA (2002) 99:9404–9409.
  • GARN H, SCHMIDT A, GRAU V et a/.: IL-24 is expressed by rat and human macrophages. Immunobiology (2002) 205:321–334.
  • •Shows that IL-24 is produced by macrophages.
  • EKMEKCIOGLU S, ELLERHORST J, MHASHILKAR AM etal.: Down-regulated melanoma differentiation associated gene (mda-4 expression in human melanomas. Int. Cancer (2001) 94:54–59.
  • ELLERHORST JA, PRIETO VG, EKMEKCIOGLU S et al.: Loss of MDA-7 expression with progression of melanoma. Gin. °flea (2002) 20:1069–1074.
  • MADIREDDI MT, DENT P, FISHER PB: Regulation of mda-7gene expression during human melanoma differentiation. Oncogene (2000) 19:1362–1368.
  • MADIREDDI MT, DENT P, FISHER PB: AP-1 and C/EBP transcription factors contribute to mda-7gene promoter activity during human melanoma differentiation. Cell . Physic] (2000) 185:36–46.
  • KNAPPE A, HORS, WITTMANN S, FICKENSCHER H: Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus saimiri. Vim/. (2000) 74:3881–3887.
  • ••Description of IL-26 and its homologywith IL–10.
  • GORIS A, MARROSU MG, VANDENBROECK K: Novel polymorphisms in the IL-10-relatedAK155 gene (chromosome 12q15). Genes Liman. (2001) 2:284–286.
  • GORIS A, HEGGARTY S, MARROSU MG et al.: Linkage disequilibrium analysis of chromosome 12q14-15 in multiple sclerosis: delineation of a 118 kb interval around interferon-gamma (IFN-y) that is involved in male versus female differential susceptibility. Genes Immun. (2002) 3:470–476.
  • KOTENKO SV, PESTKA S: Jak-Stat signaltransduction pathway through the eyes of cytokine Class II receptor complexes. Oncogene (2000) 19:2557–2565.
  • JOSEPHSON K, LOGSDON NJ, WALTER MR: Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site. Immunity (2001) 15:35–46.
  • PARRISH-NOVAK J, XU W, BRENDER T et al.: Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions. J. Biol. Chem. (2002) 277:47517–47523.
  • ••Shows that IL-19, -20 and -24 share theType 1 and 2 IL-20R complexes.
  • DUMOUTIER L, LEEMANS C, LEJEUNE D, KOTENKO SV, RENAULD JC: STAT activation by IL-19, IL-20 and mda-7through IL-20 receptor complexes of two types. Immuna (2001) 167:3545–3549.
  • ••Shows that IL-19, IL-20 and IL-24 sharethe Type 1 and Type 2 IL-20R complexes.
  • SHEIKH F, BAURIN VV, LEWIS -ANTES A et al.: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2. Immuna (2003) 172:2006–2010.
  • ••Shows that IL-26 signals through the IL -20R1/IL-10R2 receptor complex.
  • PLETNEV S, MAGRACHEVA E, KOZLOV S et al.: Characterization of the recombinant extracellular domains of human interleukin-20 receptors and their complexes with interleukin-19 and interleukin-20. Biochemistry (2003) 42:12617–12624.
  • ••Shows that IL-19 and -20 bind with highaffinity to IL-20R2 alone. This creates a new site to which IL-20R1 binds, resulting in formation of a signaling receptor complex that consists of one ligand molecule and one molecule of each receptor chain.
  • KOTENKO SV, IZOTOVA LS, MIROCHNITCHENKO OV et al.: Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-101213) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J. Biol. Chem. (2001) 276:2725–2732.
  • •Characterisation of the IL-22 receptor complex.
  • AGGARWAL S, XIE MH, MARUOKA M, FOSTER J, GURNEY AL: Acinar cells of the pancreas are a target of interleukin-22. .1 Interferon Cytokine Res. (2001) 21:1047–1053.
  • TACHIIRI A, IMAMURA R, WANG Y et al.: Genomic structure and inducible expression of the IL-22 receptor a chain in mice. Genes Inman. (2003) 4:153–159.
  • LI J, TOMKINSON N, TAN XY et al: Temporal associations between IL-22 and the extracellular domains of IL-22R and IL-10R2. Eur. Cytokine Netw. (2003) 14:91.
  • LECART S, MOREL F, NORAZ N et al.: IL-22, in contrast to IL-10, does not induce Ig production, due to absence of a functional IL-22 receptor on activated human B cells. bit. Immunol. (2002) 14:1351–1356.
  • RAMESH R, MHASHILKAR AM, TANAKA F et al.: Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor. Cancer Res. (2003) 63:5105–5113.
  • ••Demonstrates that IL-24 inhibitsendothelial cell differentiation and migration by acting via the IL-22 receptor.
  • DUMOUTIER L, LEJEUNE D, COLAU D, RENAULD JC: Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22. J. Immunol. (2001) 166:7090–7095.
  • •Description of IL-22BP and characterisation of its role as an IL-22 antagonist.
  • KOTENKO SV, IZOTOVA LS, MIROCHNITCHENKO OV et al.: Identification, cloning and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity. Immunol. (2001) 166:7096–7103.
  • •Description of IL-22BP and characterisation of its role as an IL-22 antagonist.
  • XU W, PRESNELL SR, PARRISH -NOVAK J et al.: A soluble Class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist. Proc. Natl. Acad. &L USA (2001) 98:9511–9516.
  • •Description of IL-22BP and characterisation of its role as an IL-22 antagonist.
  • GRUENBERG BH, SCHOENEMEYER A, WEISS B et al.: A novel, soluble homologue of the human IL-10 receptor with preferential expression in placenta. Genes Immunol. (2001) 2:329–334.
  • DOKKA S, SHI X, LEONARD S et al.: Interleukin-10-mediated inhibition of free radical generation in macrophages. Am. .1. Physiol. Lung Cell. Mol. Physiol. (2001) 280:L1196–L1202.
  • LEBWOHL M: Psoriasis. Lancet (2003) 361:1197–1204.
  • RICH BE: IL-20: a new target for the treatment of inflammatory skin disease. Expert Opin. Ther. Targets (2003) 7:165–174.
  • •Review of the role of IL-20 in skin inflammation.
  • WANG YC, LI HL, CHEN P et al: IL-20:promoter analysis and characterization of biological function. Ear: Cytokine Netw. (2003) 14:64.
  • KONDO M, WAGERS AJ, MANZ MG et al.: Biology of hematopoietic stem cells and progenitors: implications for clinical application. Ann. Rev Immunol. (2003) 21:759–806.
  • LIU L, DING C, ZENG W et al: Selective enhancement of multipotential hematopoietic progenitors M vitro and in vivo by IL-20. Blood (2003) 102:3206–3209.
  • ••Demonstrates that IL-20 selectivelyenhances the proliferation of multipotential haematopoietic progenitors.
  • LEJEUNE D, DUMOUTIER L, CONSTANTINESCU S et al: Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J. Biol Chem. (2002) 277:33676–33682.
  • ••Analysis of the signaling pathwaysrecruited by IL-22 in hepatoma cells. Demonstrates that IL-22, but not IL-10, induces STAT3 serine phosphorylation and MAPK activation.
  • RESMINI C, SHIELDS KM, LAMBERT AJ et al.: An anti-murine IL-22 monoclonal antibody decreases disease severity in a murine model of collagen induced arthritis. Ear: Cytokine Netw. (2003) 14:129.
  • GABAY C, KUSHNER I: Acute-phase proteins and other systemic responses to inflammation. N Engl. I Med. (1999) 340:448–454.
  • DESIDERIO S, Y00 JY: A genome-wideanalysis of the acute-phase response and its regulation by Stat3-3. Ann. NY Acad. Sci. (2003) 987:280–284.
  • BAEZA N, SANCHEZ D, CHRISTA L et al.: Pancreatitis-associated protein (HIP/PAP) gene expression is upregulated in NOD mice pancreas and localized in exocrine tissue during diabetes. Digestion (2001) 64:233–239.
  • VASSEUR S, FOLCH-PUY E, HLOUSCHEK V et al.: P8 improves pancreatic response to acute pancreatitis by enhancing the expression of the anti-inflammatory protein PAP I.,/ Biol. Chem. (2003) [Epub ahead of print].
  • HOLMDAHL R, BOCKERMANN R, BACKLUND J, YAMADA H: The molecular pathogenesis of collagen-induced arthritis in mice-a model for rheumatoid arthritis. Ageing Res. Rev (2002) 1:135–147.
  • JIANG H, SU ZZ, LIND et aL: The melanoma differentiation associated gene mda-7suppresses cancer cell growth. Proc. Natl. Acad Sci.USA (1996) 93:9160–9165.
  • •First demonstration of the anti-tumour activity of Ad.mda-7
  • SU ZZ, MADIREDDI MT, LIN JJ et al: The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice. Proc. Nati Acad. Sci.USA (1998) 95:14400–14405.
  • LEBEDEVA IV, SU ZZ, CHANG Y et al.: The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells. Oncogene (2002) 21:708–718.
  • MHASHILKAR AM, SCHROCK RD, HINDI M et al.: Melanoma differentiation associated gene-7 (mda-4: a novel anti-tumor gene for cancer gene therapy. Mol. Med. (2001) 7:271–282.
  • FISHER PB, GOPALKRISHNAN RV, CHADA S et al.: Mda-7/I1-24, a novel cancer-selective apoptosis-inducing cytokine gene: from the laboratory into the clinic. Cancer Biol. Ther. (2003) 2:S23–S37.
  • •Review of the potential of Ad.mda-7for cancer gene therapy.
  • SU ZZ, LEBEDEVA IV, SARKAR D et al: Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner. Oncogene (2003) 22:1164–1180.
  • SARKAR D, SU ZZ, LEBEDEVA IV et al.: Mda-7 (11,-24) mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK. Proc. Nati Acad. SciUSA (2002) 99:10054–10059.
  • CAO XX, MOHUIDDIN I, CHADA S et al.: Adenoviral transfer of mda-71eads to BAX up-regulation and apoptosis in mesothelioma cells, and is abrogated by over-expression of BCL-XL. Mol Med. (2002) 8:869–876.
  • LEBEDEVA IV, SARKAR D, SU ZZ et al.: Bc1-2 and Bc1-x(L) differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation-associated gene-7, mda-711L-24. Oncogene (2003) 22:8758–8773.
  • SAEKI T, MHASHILKAR A, CHADA S et al.: Tumor-suppressive effects by adenovirus-mediated mda-7gene transfer in non-small cell lung cancer cell M vitro. Gene Ther: (2000) 7:2051–2057.
  • PATAER A, CHADA S, HUNT KK, ROTH JA, SWISHER SG: Adenoviral melanoma differentiation-associated gene 7 induces apoptosis in lung cancer cells through mitochondrial permeability transition-independent cytochrome c release. Thome. Cardiovasc. Surg. (2003) 125:1328–1335.
  • GIL J, ESTEBAN M: The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-a receptors. Oncogene (2000) 19:3665–3674.
  • MHASHILKAR AM, STEWART AL, SIEGER K et al.: MDA-7 negatively regulates the P-catenin and PI3K signaling pathways in breast and lung tumor cells. Ther . (2003) 8:207–219.
  • CHANG F, LEE JT, NAVOLANIC PM et al.: Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia (2003) 17:590–603.
  • LI H, PAMUKCU R, THOMPSON WJ: I3-Catenin signaling: therapeutic strategies in oncology. Cancer Biol. The]: (2002) 1:621–625.
  • SAEKI T, MHASHILKAR A, SWANSON X et al.: Inhibition of human lung cancer growth following adenovirus-mediated mda-7gene expression in vivo. Oncogene (2002) 21:4558–4566.
  • REED JC: Apoptosis-targeted therapies for cancer. Cancer Cell (2003) 3:17–22.
  • YACOUB A, MITCHELL C, BRANNON J et al.: MDA-7 (interleukin-24) inhibits the proliferation of renal carcinoma cells and interacts with free radicals to promote cell death and loss of reproductive capacity. Mol Cancer Ther: (2003) 2:623–632.
  • YACOUB A, MITCHELL C, LISTER A et al: Melanoma differentiation-associated 7 (interleukin 24) inhibits growth and enhances radiosensitivity of glioma cells in vitro and in vivo. Clin. Cancer Res. (2003) 9:3272–3281.
  • CHEN J, CHADA S, MHASHILKAR A, MIANO JM: Tumor suppressor MDA-7/IL-24 selectively inhibits vascular smooth muscle cell growth and migration. Mol Ther: (2003) 8:220–229.
  • SAUANE M, GOPALKRISHNAN RV, LEBEDEVA I et al.: Mda-7/IL-24 induces apoptosis of diverse cancer cell lines through JAK/STAT-independent pathways. I Cell. Physiol (2003) 196:334–345.
  • •Shows that Ad.mda-7induces apoptosis in cancer cells via mechanisms that do not involve JAK/STAT signaling.
  • KAWABE S, NISHIKAWA T, MUNSHI A et al.: Adenovirus-mediated mda-7gene expression radiosensitizes non-small cell lung cancer cells via TP53-independent mechanisms. Mol Ther. (2002) 6:637–644.
  • YACOUB A, MITCHELL C, LEBEDEVA IV et al.: Mda-7 (IL-24) inhibits growth and enhances radiosensitivity of glioma cells M vitro via JNK signaling. Cancer Biol. Ther. (2003) 2:347–353.
  • SU Z, LEBEDEVA IV, GOPALKRISHNAN RV et al: A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells. Proc. Nat] Acad. Sci.USA (2001) 98:10332–10337.
  • EKMEKCIOGLU S, ELLERHORST JA, MUMM JB et al.: Negative association of melanoma differentiation-associated gene (mda- and inducible nitric oxide synthase (iNOS) in human melanoma: MDA-7 regulates iNOS expression in melanoma cells. Ma Cancer Ther. (2003) 2:9–17.
  • LIRK P, HOFFMANN G, RIEDER J: Inducible nitric oxide synthase-time for reappraisal. Cur]: Drug Targets Inflamm. Allergy (2002) 1:89–108.
  • GOPALKRISHNAN R: INGN-241. Introgen. Carr. Opin. Investig. Drugs (2002) 3:1773–1777.
  • CHADA S, NEMUNAITIS J, TONG Aet al.: Phase I dose-escalation study of Ad- mda7 (INGN-241) in patients with advanced carcinoma. Cancer Gene Ther: (2001) 8:S3.
  • KANITAKIS J, BUTNARU AC, CLAUDY A: Novel biological immunotherapies for psoriasis. Expert Opin. Investig. Drugs (2003) 12:1111–1121.

Websites

  • http://www.introgen.com/ Introgen Therapeutics homepage.
  • http://www.zymogenetics.com/ Zymogenetics homepage.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.